Roche and GE Healthcare Launch NAVIFY Tumor Board 2.0 for Personalized Treatment Decision in Cancer Care

Roche and GE Healthcare Launch NAVIFY Tumor Board 2.0 for Personalized Treatment Decision in Cancer Care

Shots:

  • The NAVIFY Tumor Board 2.0 with medical imaging capabilities brings a personalized treatment in patients with cancer with its initial availability in the US & Canada
  • The tumor board enables radiologists to upload their patient records to the same dashboard where the patient’s previous treatment details are stored, helping the clinicians to have a quick review of all relevant files and to choose the best treatment for each cancer patient
  • The NAVIFY tumor board is a web-based cancer care team workflow tool, presenting data in a dashboard and standardizes processes to encourage collaboration on patient treatment decisions

Click here to read full press release/ article | Ref: Roche | Image: The Business Journals